Last modified by ddiadm - 2 years ago

Erin Kershaw, MD

Chief, Division of Endocrinology and Metabolism Endowed Chair for Obesity and Diabetes Research Associate Professor of Medicine

I have broad experience in the field of endocrinology, diabetes, and metabolism including over 25 years specifi-cally devoted to clinical and scientific efforts to understand obesity, diabetes, and their complications. I have developed specific expertise in key research areas including metabolic assessment of cells, mice, and humans. My research program focuses on defining mechanisms by which lipid and steroid metabolism contribute to nor-mal metabolism and disease. Most recently, my research efforts have focused on pathways of triacylglycerol hydrolysis (lipolysis). Another major focus of my research program is to identify and characterize proteins and pathways that contribute to metabolic disease. These efforts fall into two main areas: 1) characterizing novel adipocyte-secreted factors and their relationship to metabolic disease in humans, and 2) characterizing novel genes/loci linked to metabolic disease in humans. We use a combination of molecular, cellular, physiological, and translational approaches. Our ultimate goal is to develop more effective strategies for prevention and treat-ment of obesity, diabetes, and their complications. I have successfully competed for and administered grants to fund my research including grants from the Howard Hughes Medical Institute, American Diabetes Association, and the National Institutes of Health. I also have experience serving in large, multi-institutional research consor-tiums (i.e. U01 AR071130-01, UG3 DK119973). I currently hold several leadership roles, including Chief of the Division of Endocrinology, Associate Program Director for the Clinical Endocrinology Fellowship Program, and Oversight/Steering Committee Member for the T32 Training Program in Endocrinology, and Metabolism. This experience is enriched by clinical expertise and board certification in 1) Endocrinology, Diabetes, and Metabo-lism, 2) Clinical Lipidology, and 3) Obesity Medicine. Thus, I have demonstrated a record of successful and productive research, clinical activity, and leadership in the field of endocrinology, diabetes, and metabolism.

Primary Address
W1055 Biomedical Science Tower
BioSketch
WordPress Image Lightbox Plugin